214699-26-0 Usage
General Description
5,6,7,8-Tetrahydro-6-(phenylmethyl)-1,6-naphthyridin-3-amine is a chemical compound with the molecular formula C20H22N2. It is a naphthyridine derivative, which has a bicyclic structure with a naphthalene and pyridine ring system. The compound possesses a tetrahydro-1,6-naphthyridine core with an amine group in position 3 and a phenylmethyl substituent in position 6. It is used as a building block in the synthesis of pharmaceutical compounds, and it exhibits potential bioactive properties. The chemical structure of 5,6,7,8-tetrahydro-6-(phenylmethyl)-1,6-naphthyridin-3-amine makes it a valuable intermediate in the development of novel drugs targeting various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 214699-26-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,4,6,9 and 9 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 214699-26:
(8*2)+(7*1)+(6*4)+(5*6)+(4*9)+(3*9)+(2*2)+(1*6)=150
150 % 10 = 0
So 214699-26-0 is a valid CAS Registry Number.
InChI:InChI=1/C15H17N3/c16-14-8-13-11-18(7-6-15(13)17-9-14)10-12-4-2-1-3-5-12/h1-5,8-9H,6-7,10-11,16H2
214699-26-0Relevant articles and documents
An expeditious synthesis of 3-(difluoromethoxy)- and 3-(trifluoromethoxy)-5,6,7,8-tetrahydro-1,6-naphthyridines
Guiadeen, Deodialsingh,Kothandaraman, Shankaran,Yang, Lihu,Mills, Sander G.,MacCoss, Malcolm
scheme or table, p. 6368 - 6370 (2009/04/07)
An expeditious and concise synthesis of 3-(difluoromethoxy)-5,6,7,8-tetrahydro-1,6-naphthyridine and 3-(trifluoromethoxy)-5,6,7,8-tetrahydro-1,6-naphthyridines is described. Starting from N-benzyl piperidone, the key intermediates leading to these two bio
A facile synthesis of the 3-amino-5,6,7,8-tetrahydro[1,6]naphthyridine system and some alkylated and polycyclic homologues
Harling,Harrington,Thompson
, p. 787 - 797 (2007/10/03)
A facile, two step synthesis of the 3-amino-5,6,7,8-tetrahydro[1,6]naphthyridine system 1 and its more substituted homologues 2-5 via the condensation of mono- and bicyclic-4-piperidinones 11a-c, 12-14 with 3,5-dinitro-1-methyl-2-pyridone 6 in the presenc
